Prosecution Insights
Last updated: October 02, 2026

Examiner: HOLWERDA, KATHLEEN SONNETT

Tech Center 4100 • Art Units: 3731 3771 4100

This examiner grants 69% of resolved cases

Analysis

Kathleen Sonnett Holwerda operates within Art Unit 3731 of Tech Center 4100. She has managed 970 resolved cases, demonstrating a significant volume of experience in this specific area of patent examination. Her allowance rate stands at 68.7 percent, which serves as the primary benchmark for outcomes in her docket.

Practitioners should note the impact of personal communication on her decision-making process. The data shows an interview lift of 17.8 percent, suggesting that engaging in an interview increases the probability of securing an allowance compared to cases without such interaction. This lift is a critical factor for attorneys to consider when developing their prosecution strategy.

The timeline for reaching a final disposition is also a key metric. The median days to allowance for this examiner is 1366. This figure provides a clear expectation for the duration of the prosecution cycle from filing to a successful grant. Understanding this timeframe helps in managing client expectations regarding the speed of the patenting process for the 970 resolved cases in Art Unit 3731.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.7%
Allow Rate
+8.7% vs TC avg
1,019
Total Applications
+17.8%
Interview Lift
1366
Avg Prosecution Days
Based on 970 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
21.5%
§102 Novelty
46.7%
§103 Obviousness
22.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18975257 ENDOVASCULAR DEVICES AND METHODS FOR EXPLOITING INTRAMURAL SPACE Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
18213223 Thrombectomy Apparatuses Final Rejection Boston Scientific Scimed, Inc.
18107182 METHODS OF TREATING VASCULAR LESIONS Final Rejection BOSTON SCIENTIFIC SCIMED, INC.
18931414 SURGICAL INSTRUMENT WITH MULTI-FUNCTION BUTTON Non-Final OA Cilag GmbH International
17705985 CUTTING DEVICES FOR SUTURING TOOLS AND RELATED SYSTEMS AND METHODS Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
19195670 VASO-OCCLUSIVE DEVICES FOR OCCLUDING BLOOD VESSELS AND METHODS FOR MAKING AND USING SAME Non-Final OA STRYKER EUROPEAN OPERATIONS LIMITED
18855942 BENDABLE OPTICAL TROCAR ASSEMBLY Final Rejection MEDTRONIC, INC.
18592323 ARTICULATING SURGICAL INSTRUMENTS Final Rejection C.R. Bard, Inc.
18446036 STEERABLE AND EXPANDABLE ASPIRATION CATHETER Non-Final OA DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY
18584340 LESION RETRIEVAL DEVICE AND ATHERECTOMY DEVICE Final Rejection ASAHI INTECC CO., LTD.
19171835 ADVANCED ELECTRODE ARRAY INSERTION Non-Final OA Cochlear Limited
18339584 CATHETER ASSEMBLY AND USE METHOD Non-Final OA Terumo Kabushiki Kaisha
18887772 IMPLANT DELIVERY SYSTEM Non-Final OA MicroVention, Inc.
18313305 DEVICES FOR VASCULAR OCCLUSION Non-Final OA MicroVention, Inc.
19193790 DEVICES AND METHODS FOR INTRAOCULAR TISSUE MANIPULATION Non-Final OA Sight Sciences, Inc.
19190952 FORCEPS INCLUDING A PRE-LOADED HANDLE LATCH Non-Final OA GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
18428976 INTRAVASCULAR LITHOTRIPSY CATHETER WITH MOVABLE EMITTERS Final Rejection Shockwave Medical, Inc.
18428752 INTRAVASCULAR LITHOTRIPSY CATHETER WITH MOVABLE EMITTERS Non-Final OA Shockwave Medical, Inc.
18702090 VASCULAR OCCLUSION DEVICES AND METHODS FOR OCCLUDING A VESSEL Non-Final OA Bard Peripheral Vascular, Inc.
18546206 A SELF-EXPANDABLE MEDICAL DEVICE FOR ADVANCEMENT THROUGH VASCULATURE TO AN EXPANSION SITE IN A BLOOD VESSEL Non-Final OA ANACONDA BIOMED, S.L.
18546190 AN EXPANDABLE CLOT MOBILIZER DEVICE FOR EXTRACTION OF AN OCCLUSION FROM A BLOOD VESSEL Final Rejection Anaconda Biomed, S.L.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month